SWTX (springworkstx.com) מקדם שווי פעילות להכנסות

סמלים רשמיים של חברת SpringWorks Therapeutics Inc. (SWTX)

Due to patent protection and the uniqueness of its drugs, SpringWorks Therapeutics (SWTX) possesses pricing power and a stable cash flow. The change in the company's enterprise value-to-revenue ratio demonstrates the business's resilience to crises, while captures the current value of the indicator. R&D activity aimed at expanding molecular indications and management's experience in commercializing targeted therapies ensure the steady development of the biopharmaceutical startup.

springworkstx.com (SWTX): מכפיל EV/Sales מ-04.07.2022 עד 19.11.2026

פילוחי מדדים פיננסיים ומדדי שוק עבור SpringWorks Therapeutics, Inc. (SWTX)

- מחיר ותחזית קונצנזוס למחירים:
- מדדי הערכת שווי שוק של העסק:
הערכת שווי פונדמנטלית של החברה:SpringWorks Therapeutics SWTX
דוגמת מוצר של springworkstx.com

This indicator measures the enterprise value, including debt and subtracting cash, relative to sales to assess the market premium paid per unit of revenue. By analyzing the enterprise value to revenue ratio for SpringWorks Therapeutics (SWTX), an investor can evaluate the extent to which the biotech's capitalization is overvalued against the risks of nirogacestat clinical trial failures and reliance on external financing.